Methotrexate and Prednisolone study in Erythema Nodosum Leprosum - MaPs in E

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•All of the following six criteria must be met in order for an individual to be eligible (only one of 6A to 6D need to be met):
•1. Individuals who diagnosed with leprosy complicated by ENL
•2. Individuals with ENL aged 18-60 years old
•3. Individuals with ENL deteriorating symptoms
•4. Individuals with 10 or more tender, papular or nodular ENL skin lesions
•5. Individuals with an EESS score of at least 9
•6. Individuals with ENL on:
•A. No current anti- ENL treatment
•B. Prednisolone up to 30mg per day (if ACUTE) or Prednisolone 10-30mg (inclusive) per day (if RECURRENT/ CHRONIC) or equivalent alternative corticosteroid dose OR
•C. Thalidomide or other non-steroidal anti-ENL medication OR
•D. A combination of prednisolone (up to 30mg) and another non-steroidal anti-ENL medication (thalidomide, clofazimine, azathioprine, pentoxifylline, ciclosporin, minocycline)

•1) Individuals who were first diagnosed with ENL more than 4 years prior to enrolment
•2) Individuals less than 18 years old or older than 60 years
•3) Individuals weighing less than 35kg
•4) Individuals with 9 or fewer tender, popular or nodular ENL skin lesions
•5) Individuals with an EESS score of 8 or less
•6) Women of child bearing capacity who decline to use two forms of adequate contraception and men who decline to use two forms of adequate contraception
•7) Pregnant or breastfeeding women
•8) Individuals with recurrent or chronic ENL who deteriorate on a dose of prednisolone less than 10 mg or more than 30 mg
•9)Individuals who have taken methotrexate by any route for the last 12 weeks
•10)Individuals with a hypersensitivity to methotrexate or a recognised contraindication ( please see Methotrexate information sheet)
•11) Individuals currently diagnosed with Type 1 reaction or Lucioâ??s phenomenon
•12) Individuals with the severe abnormalities in screening investigations
•13) Positive serology for HIV, Hepatitis B or C
•14) Evidence of tuberculosis or pulmonary fibrosis
•15) A history of chronic liver disease or excessive alcohol or illicit substance consumption
•16) Individuals with severe inter-current infections, uncontrolled diabetes, active peptic ulcer disease, untreated malignancy
•17) Individuals unable to attend regularly for assessment or monitoring

发起方

ondon School of Hygiene and Tropical Medicine